TAVR at 20: How Much Longer Will Medicare Mandate a Registry? Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
Heart Failure From Meth Use: Growing Beast Lurks in the Shadows Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
Early Cardiac Amyloidosis Still Bad News Without Treatment Observational study supports treating even asymptomatic patients Nov 16, 2022
Upfront ECMO Disappoints for Cardiogenic Shock High-cost procedure not yet justified as an early strategy Nov 07, 2022
Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study Nov 05, 2022
Empagliflozin Protects At-Risk Patients From CKD Progression Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
Outpatient Centers Cautiously Open Doors to Surgery for People With Cardiac Devices Will those with CIEDs become regular patients at ambulatory surgery centers within a decade? Oct 25, 2022
Despite Exciting Newcomer Drugs, Uptake of HF Meds Still Meek Across Oceans U.S. not alone in slow initiation, low target-dose achievement, and early discontinuation Oct 14, 2022
Lower Entresto Doses Suffice in the Real World Reassuring findings for patients who don't tolerate the maximum ARNI dose Oct 10, 2022
FDA Approves At-Home Furosemide for Heart Failure Strong diuretic to become available outside the hospital setting Oct 10, 2022
Salt Pills During Diuresis: Acute HF Patients Neither Helped Nor Harmed Small randomized trial challenges conventional thinking about sodium Oct 05, 2022
Concurrent LAA Occlusion Loses Its Appeal for LVAD Surgeons Heart pump placement plus anticoagulation suffice for patients, even those with Afib Oct 05, 2022
The Search Is On for Another Xeno Heart Transplant Recipient Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Data Analyses continue to support wider adoption of dapagliflozin, researchers say Oct 03, 2022
Growing Calls to Marry HF Specialists With Cardiac Critical Care Cardiac ICU staffing issues require a multidisciplinary team approach, some say Oct 02, 2022
MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven Large trial comes up short in proving a definitive benefit to debris filters Sep 17, 2022
Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstanding Complication of ablation not associated with worse outcomes at 5 years Sep 14, 2022
Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease Randomized trial provides "definitive" evidence against revascularizing stable cases Aug 27, 2022
Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
No Detrimental Impact on Cognition With Entresto for Heart Failure Cost may be reason for underutilization, rather than concerns about cognition, expert noted Aug 26, 2022
No Worsening Cardiac Dysfunction in Long COVID Other harms likely contribute to dyspnea, HF after COVID-19 hospitalization Aug 05, 2022
Heart Disease Will Surge Over the Coming Decades Worsening racial disparities are also projected Aug 01, 2022
Fluid Therapy Showdown in Cardiac Surgery Disfavors Albumin Major adverse events not reduced, and some complications increased Jul 19, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
Which Advanced HF Patients Are Entresto-Intolerant in the Real World? 1 in 6 dropped out from the LIFE trial because of side effects Jun 27, 2022
Heart Failure Drugs Can Be Unaffordable on Medicare, Study Finds Older adults are subject to cost-sharing and other medication coverage restrictions Jun 21, 2022
TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain Do worst-performing sites need more education about best practices? Jun 12, 2022
Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
Good News for Heart Failure Patients Getting COVID Booster Shots Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
